Cargando…

Generation and evaluation of antibody agents for molecular imaging of CD44v6-expressing cancers

AIM: The aim of this study was to generate and characterize scFv antibodies directed to human CD44v6, as well as to radiolabel and evaluate top candidates in vitro and in vivo for their potential use in CD44v6-targeted molecular imaging in cancer patients. MATERIALS AND METHODS: Phage display select...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haylock, Anna-Karin, Nilvebrant, Johan, Mortensen, Anja, Velikyan, Irina, Nestor, Marika, Falk, Ronny
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630320/ https://www.ncbi.nlm.nih.gov/pubmed/29029420 http://dx.doi.org/10.18632/oncotarget.17996

Ejemplares similares

Evaluation of a novel type of imaging probe based on a recombinant bivalent mini-antibody construct for detection of CD44v6-expressing squamous cell carcinoma
por: HAYLOCK, ANNA-KARIN, et al.
Publicado: (2015)

In vivo characterization of the novel CD44v6-targeting Fab fragment AbD15179 for molecular imaging of squamous cell carcinoma: a dual-isotope study
por: Haylock, Anna-Karin, et al.
Publicado: (2014)

Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy
por: Mortensen, Anja C., et al.
Publicado: (2018)

CD44v6-Targeted Imaging of Head and Neck Squamous Cell Carcinoma: Antibody-Based Approaches
por: Spiegelberg, Diana, et al.
Publicado: (2017)

Selection, characterization and in vivo evaluation of novel CD44v6-targeting antibodies for targeted molecular radiotherapy
por: Mortensen, A. C. L., et al.
Publicado: (2023)

Molecular imaging of EGFR and CD44v6 for prediction and response monitoring of HSP90 inhibition in an in vivo squamous cell carcinoma model
por: Spiegelberg, Diana, et al.
Publicado: (2015)

Prospective of (68)Ga Radionuclide Contribution to the Development of Imaging Agents for Infection and Inflammation
por: Velikyan, Irina
Publicado: (2018)

Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells
por: Sahlberg, Sara Häggblad, et al.
Publicado: (2014)

Advances in GLP-1 receptor targeting radiolabeled agent development and prospective of theranostics
por: Velikyan, Irina, et al.
Publicado: (2020)

CD44s and CD44v6 Expression in Head and Neck Epithelia
por: Mack, Brigitte, et al.
Publicado: (2008)

A Novel Anti-CD44 Variant 3 Monoclonal Antibody C(44)Mab-6 Was Established for Multiple Applications
por: Suzuki, Hiroyuki, et al.
Publicado: (2023)

Molecular Imaging and Radiotherapy: Theranostics for Personalized Patient Management
por: Velikyan, Irina
Publicado: (2012)

Monoclonal antibodies to CD44 and their influence on hyaluronan recognition
Publicado: (1995)

The Role of CD44 in Disease Pathophysiology and Targeted Treatment
por: Jordan, Andre R., et al.
Publicado: (2015)

Modulation of CD44 Activity by A6-Peptide
por: Finlayson, Malcolm
Publicado: (2015)

Immunohistochemical analysis of CD44s and CD44v6 in endometriosis and adenomyosis : comparison with normal, hyperplastic, and malignant endometrium.
por: Lin, Z., et al.
Publicado: (2001)

CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression
por: Wang, Zhe, et al.
Publicado: (2018)

Development of a Novel Anti-CD44 Variant 6 Monoclonal Antibody C(44)Mab-9 for Multiple Applications against Colorectal Carcinomas
por: Ejima, Ryo, et al.
Publicado: (2023)

Engineering Modular Half-Antibody Conjugated Nanoparticles for Targeting CD44v6-Expressing Cancer Cells
por: Lourenço, Bianca N., et al.
Publicado: (2021)

Characterization of CD44 variant expression in head and neck squamous cell carcinomas
por: Spiegelberg, D., et al.
Publicado: (2013)

Domain‐specific CD6 monoclonal antibodies identify CD6 isoforms generated by alternative‐splicing
por: Santos, Rita F., et al.
Publicado: (2019)

CD44 Antibodies and Immune Thrombocytopenia in the Amelioration of Murine Inflammatory Arthritis
por: Mott, Patrick J., et al.
Publicado: (2013)

CD44v6 engages in colorectal cancer progression
por: Ma, Lixin, et al.
Publicado: (2019)

Understanding the role of CD44V6 in ovarian cancer
por: Zhang, Hui-Feng, et al.
Publicado: (2017)

CD44 regulates Wnt signaling at the level of LRP6
por: Orian-Rousseau, Véronique, et al.
Publicado: (2015)

The liberation of CD44
por: Cichy, Joanna, et al.
Publicado: (2003)

Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan
Publicado: (1996)

Functional Genomic mRNA Profiling of Colorectal Adenomas: Identification and in vivo Validation of CD44 and Splice Variant CD44v6 as Molecular Imaging Targets
por: Hartmans, Elmire, et al.
Publicado: (2017)

Internalization of Met Requires the Co-Receptor CD44v6 and Its Link to ERM Proteins
por: Hasenauer, Susanne, et al.
Publicado: (2013)

Detection of high CD44 expression in oral cancers using the novel monoclonal antibody, C(44)Mab-5
por: Yamada, Shinji, et al.
Publicado: (2018)

Development of a Novel Anti-CD44 Variant 4 Monoclonal Antibody C(44)Mab-108 for Immunohistochemistry
por: Suzuki, Hiroyuki, et al.
Publicado: (2023)

Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells
Publicado: (1991)

Near-Infrared Fluorescence Molecular Imaging of Ductal Carcinoma In Situ with CD44v6-Specific Antibodies in Mice: A Preclinical Study
por: Vermeulen, Jeroen F., et al.
Publicado: (2012)

Prospective of (68)Ga-Radiopharmaceutical Development
por: Velikyan, Irina
Publicado: (2013)

(68)Ga-Based Radiopharmaceuticals: Production and Application Relationship
por: Velikyan, Irina
Publicado: (2015)

(Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer
por: Velikyan, Irina
Publicado: (2020)

Bivalent binding on cells varies between anti-CD20 antibodies and is dose-dependent
por: Bondza, Sina, et al.
Publicado: (2020)

Increased CD44s and decreased CD44v6 RNA expression are associated with better survival in myxofibrosarcoma patients: a pilot study
por: Matuschek, Christiane, et al.
Publicado: (2014)

Isolation of All CD44 Transcripts in Human Epidermis and Regulation of Their Expression by Various Agents
por: Teye, Kwesi, et al.
Publicado: (2016)

Characterizing CD44 regulatory microRNAs as putative therapeutic agents in human melanoma
por: Fänder, Johannes, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pmevbmeig681sc4r2l5f3omdaa